1 |
1% lignocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
084 1件: 84 💬 |
2 |
13nh3 pet/ct scan |
- |
- |
- |
- |
084 1件: 84 💬 |
3 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
4 |
18f-fluorodeoxyglucose |
- |
- |
- |
- |
084 1件: 84 💬 |
5 |
18f-fspg |
Florilglutamic acid F-18 |
- |
- |
- |
084 1件: 84 💬 |
6 |
18fdg pet/ct scan |
- |
- |
- |
- |
084 1件: 84 💬 |
7 |
2% lignocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
084 1件: 84 💬 |
8 |
68ga-dotanoc |
- |
- |
- |
- |
084 1件: 84 💬 |
9 |
68ga-dotatate |
Dotatate |
- |
- |
- |
084 1件: 84 💬 |
10 |
68ga-dotatate pet/ct |
Dotatate |
- |
- |
- |
084 1件: 84 💬 |
11 |
99m technetium infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
084 1件: 84 💬 |
12 |
99mtc-infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
084 1件: 84 💬 |
13 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
14 |
Abpc |
Ampicillin |
3件: D00204 D00204, D01251 D01251, D02119 D02119 💬 |
- |
- |
084 1件: 84 💬 |
15 |
Act-293987 / jnj-67896049 |
- |
- |
- |
- |
084 1件: 84 💬 |
16 |
Acthar |
- |
- |
- |
- |
002 9件: 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
17 |
Acthar gel |
- |
- |
- |
- |
013 6件: 13, 46, 49, 50, 84, 222 💬 |
18 |
Acthar gel (adrenocorticotropic hormone) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
19 |
Acthar gel 40 units twice weekly |
- |
- |
- |
- |
084 1件: 84 💬 |
20 |
Acthar gel 80 units twice weekly. |
- |
- |
- |
- |
084 1件: 84 💬 |
21 |
Acz885 |
- |
- |
- |
- |
046 7件: 46, 84, 106, 107, 108, 266, 267 💬 |
22 |
Adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
23 |
Adrenocorticotropic hormone |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 3件: 13, 50, 84 💬 |
24 |
All subjects will receive maraviroc 300mg orally twice a day for 6 weeks |
Maraviroc |
1件: D06670 D06670 💬 |
CCR5 1件: CCR5 💬 |
Chemokine signaling pathway 9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
084 1件: 84 💬 |
25 |
Allogeneic stem cell transplantation |
- |
- |
- |
- |
049 2件: 49, 84 💬 |
26 |
Ambrisentan |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
27 |
Ampc |
Cyclic adenosine monophosphate |
- |
- |
- |
084 1件: 84 💬 |
28 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
29 |
Analysis of gamma globulin |
- |
- |
- |
- |
084 1件: 84 💬 |
30 |
Antibiotic regimen |
- |
- |
- |
- |
084 1件: 84 💬 |
31 |
Antituberculous therapy along with steroids |
- |
- |
- |
- |
084 1件: 84 💬 |
32 |
Ara 290 |
- |
- |
- |
- |
084 1件: 84 💬 |
33 |
Armodafinil |
Armodafinil |
1件: D03215 D03215 💬 |
SLC6A3 1件: SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 3件: 6 , 13, 84 💬 |
34 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
35 |
Atyr1923 |
- |
- |
- |
- |
084 1件: 84 💬 |
36 |
Atyr1923 1.0 mg/kg |
- |
- |
- |
- |
084 1件: 84 💬 |
37 |
Atyr1923 3.0 mg/kg |
- |
- |
- |
- |
084 1件: 84 💬 |
38 |
Atyr1923 5.0 mg/kg |
- |
- |
- |
- |
084 1件: 84 💬 |
39 |
Autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
084 1件: 84 💬 |
40 |
Azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
41 |
Azithromycin 250mg capsule |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
084 1件: 84 💬 |
42 |
Azithromycin monohydrate |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
084 1件: 84 💬 |
43 |
Bal |
- |
- |
- |
- |
084 2件: 84, 299 💬 |
44 |
Bardoxolone |
Bardoxolone |
1件: D09584 D09584 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
45 |
Bardoxolone methyl |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
46 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
47 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
48 |
Bosentan monohydrate |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 4件: 51, 84, 86, 88 💬 |
49 |
C11-methionine |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
084 1件: 84 💬 |
50 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
51 |
Calcium citrate |
Calcium |
1件: D00933 D00933 💬 |
- |
- |
046 3件: 46, 84, 235 💬 |
52 |
Calcium citrate with vitamin d2 |
Calcium |
2件: D00187 D00187, D00933 D00933 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
084 1件: 84 💬 |
53 |
Canakinumab |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
54 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
55 |
Cc-100004 |
- |
- |
- |
- |
084 1件: 84 💬 |
56 |
Cc-220 |
CC-220 |
- |
- |
- |
049 2件: 49, 84 💬 |
57 |
Cc-220 0.3 mg daily |
CC-220 |
- |
- |
- |
084 1件: 84 💬 |
58 |
Cc-220 0.6mg daily |
CC-220 |
- |
- |
- |
084 1件: 84 💬 |
59 |
Ciclesonide |
Ciclesonide |
1件: D01703 D01703 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
60 |
Clarithromycin |
Clarithromycin |
1件: D00276 D00276 💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
61 |
Cmk389 |
- |
- |
- |
- |
084 1件: 84 💬 |
62 |
Cnto 148 |
- |
- |
- |
- |
046 4件: 46, 84, 97, 271 💬 |
63 |
Cnto1275 |
- |
- |
- |
- |
046 6件: 46, 49, 84, 93, 96, 97 💬 |
64 |
Cnto148 |
- |
- |
- |
- |
046 3件: 46, 84, 97 💬 |
65 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
66 |
Corticotropin |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 7件: 2 , 13, 46, 75, 78, 84, 222 💬 |
67 |
Cu-64 dotatate |
Dotatate |
- |
- |
- |
084 1件: 84 💬 |
68 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
69 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
70 |
D-methylphenidate |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
084 1件: 84 💬 |
71 |
Dapsone |
Dapsone |
1件: D00592 D00592 💬 |
- |
- |
035 4件: 35, 42, 60, 84 💬 |
72 |
Deltacortene*10cpr 25mg |
- |
- |
- |
- |
084 1件: 84 💬 |
73 |
Device: blood pressure |
- |
- |
- |
- |
084 1件: 84 💬 |
74 |
Device: flexible bronchoscopy in moderate sedation |
- |
- |
- |
- |
084 1件: 84 💬 |
75 |
Device: nested pcr for formalin-fixed tissues |
Formaldehyde |
1件: D00017 D00017 💬 |
- |
- |
084 1件: 84 💬 |
76 |
Device: nested pcr for fresh tissues |
- |
- |
- |
- |
084 1件: 84 💬 |
77 |
Device: oxygen saturation |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
084 1件: 84 💬 |
78 |
Device: propofol dosage |
Propofol |
1件: D00549 D00549 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
084 1件: 84 💬 |
79 |
Device: real-time pcr for fresh tissues |
- |
- |
- |
- |
084 1件: 84 💬 |
80 |
Device: recovery time after bronchoscopy |
- |
- |
- |
- |
084 1件: 84 💬 |
81 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
82 |
Dexamethasone 0,5mg |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
83 |
Diagnostic test: 18f-fdg-pet/mri |
Fludeoxyglucose (18F) |
- |
- |
- |
084 1件: 84 💬 |
84 |
Diagnostic test: 18f-ge180-pet/mri |
- |
- |
- |
- |
084 1件: 84 💬 |
85 |
Diagnostic test: 68ga-dota-toc pet/ct |
- |
- |
- |
- |
084 1件: 84 💬 |
86 |
Diagnostic test: fdg-pet/ct with rb82 myocardial perfusion imaging |
- |
- |
- |
- |
084 1件: 84 💬 |
87 |
Diagnostic test: laboratory testing |
- |
- |
- |
- |
084 1件: 84 💬 |
88 |
Diagnostic test: simultaneous combined 18f-fdg pet and cardiac mri imaging |
Fludeoxyglucose (18F) |
- |
- |
- |
084 1件: 84 💬 |
89 |
Diagnostic test: spirometry |
- |
- |
- |
- |
084 1件: 84 💬 |
90 |
Dotanoc |
- |
- |
- |
- |
084 1件: 84 💬 |
91 |
Dotatate |
Dotatate |
- |
- |
- |
041 3件: 41, 75, 84 💬 |
92 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
93 |
Ergocalciferol |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299 💬 |
94 |
Ethambutol |
Ethambutol |
2件: D00878 D00878, D07925 D07925 💬 |
- |
- |
084 2件: 84, 299 💬 |
95 |
Fdg |
- |
- |
- |
- |
084 1件: 84 💬 |
96 |
Fermented oyster extract |
Oyster |
- |
- |
- |
084 1件: 84 💬 |
97 |
Fludeoxyglucose |
Fludeoxyglucose |
1件: D01843 D01843 💬 |
- |
- |
034 4件: 34, 84, 85, 88 💬 |
98 |
Fluorine (18f) fludeoxyglucose |
Fludeoxyglucose |
1件: D01843 D01843 💬 |
- |
- |
084 2件: 84, 85 💬 |
99 |
Fluorodeoxyglucose |
- |
- |
- |
- |
084 1件: 84 💬 |
100 |
Folic acid |
Folic acid |
1件: D00070 D00070 💬 |
- |
- |
006 4件: 6 , 46, 49, 84 💬 |
101 |
Formalin |
Formaldehyde |
1件: D00017 D00017 💬 |
- |
- |
084 1件: 84 💬 |
102 |
Ga-68-dota-noc |
- |
- |
- |
- |
084 1件: 84 💬 |
103 |
Gallium-68 dotatate |
Dotatate |
- |
- |
- |
084 1件: 84 💬 |
104 |
Gallium-68-dota-n-octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
105 |
Genetic: rna sequencing |
- |
- |
- |
- |
084 1件: 84 💬 |
106 |
Glucocorticoid (prednisone or prednisolone) |
Prednisolone |
9件: D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
107 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
108 |
Golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 6件: 46, 56, 84, 96, 97, 271 💬 |
109 |
Golimumab liquid in prefilled syringe |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 84, 97 💬 |
110 |
H.p. acthar gel |
- |
- |
- |
- |
046 5件: 46, 49, 50, 84, 222 💬 |
111 |
Habitrol |
- |
- |
- |
- |
084 1件: 84 💬 |
112 |
Heparin |
Heparin |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
060 11件: 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 💬 |
113 |
Human anti tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 84 💬 |
114 |
Human anti-il 12/23 monoclonal antibody |
- |
- |
- |
- |
084 1件: 84 💬 |
115 |
Humira |
- |
- |
- |
- |
046 7件: 46, 84, 96, 97, 160, 269, 271 💬 |
116 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
117 |
Hydroxychloroquine + prednisone |
Hydroxychloroquine |
2件: D00473 D00473, D08050 D08050 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
118 |
Ilaris |
- |
- |
- |
- |
056 7件: 56, 84, 106, 107, 108, 266, 267 💬 |
119 |
Iloprost |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 4件: 51, 84, 85, 86 💬 |
120 |
Imod.fc, h-fcv3-n4 |
- |
- |
- |
- |
084 1件: 84 💬 |
121 |
Indium |
Indium |
- |
- |
- |
028 3件: 28, 84, 299 💬 |
122 |
Indium-111 pentreotide |
Indium |
- |
- |
- |
084 1件: 84 💬 |
123 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
124 |
Influenza vaccine |
- |
- |
- |
- |
011 5件: 11, 13, 46, 51, 84 💬 |
125 |
Inhaled treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
084 2件: 84, 86 💬 |
126 |
L-methionine |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
084 1件: 84 💬 |
127 |
L-methionine ([11c]methyl) |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
084 1件: 84 💬 |
128 |
Levaquin |
- |
- |
- |
- |
084 1件: 84 💬 |
129 |
Levofloxacin |
Levofloxacin |
2件: D00588 D00588, D08120 D08120 💬 |
- |
- |
046 4件: 46, 53, 84, 299 💬 |
130 |
Lignocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
084 1件: 84 💬 |
131 |
Low dose prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
132 |
Maraviroc |
Maraviroc |
1件: D06670 D06670 💬 |
CCR5 1件: CCR5 💬 |
Chemokine signaling pathway 9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 84 💬 |
133 |
Medium dose prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
134 |
Methionine |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
034 7件: 34, 75, 84, 93, 229, 298, 300 💬 |
135 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
136 |
Methylphenidate |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 7件: 6 , 13, 34, 84, 113, 179, 206 💬 |
137 |
Methylphenidate (overencapsulated) |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
084 1件: 84 💬 |
138 |
Methylphenidate 10mg tablets |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
084 1件: 84 💬 |
139 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
140 |
Methylprednisolone bolus iv 15 mg/kg/d for 3 days. |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
141 |
Minomycin |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
084 1件: 84 💬 |
142 |
Mtx |
- |
- |
- |
- |
035 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
143 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
144 |
N-acetyl-cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
084 1件: 84 💬 |
145 |
Nelutri™ |
- |
- |
- |
- |
084 1件: 84 💬 |
146 |
Nicotine |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 2件: 6 , 84 💬 |
147 |
Nicotine patch |
Nicotine |
3件: D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 2件: 6 , 84 💬 |
148 |
None |
- |
- |
- |
- |
046 14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
149 |
Octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
150 |
Octreotide lar / sandostatin lar (lar=long acting release) |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
151 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
152 |
Other: 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
046 2件: 46, 84 💬 |
153 |
Other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
084 1件: 84 💬 |
154 |
Other: normal saline for injection |
- |
- |
- |
- |
084 1件: 84 💬 |
155 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
156 |
Oyster |
Oyster |
- |
- |
- |
084 1件: 84 💬 |
157 |
Pd 0360324 |
- |
- |
- |
- |
046 2件: 46, 84 💬 |
158 |
Pda001 (cenplacel-l) |
- |
- |
- |
- |
084 1件: 84 💬 |
159 |
Pentoxifylline |
Pentoxifylline |
1件: D00501 D00501 💬 |
- |
- |
026 10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
160 |
Pirfenidone |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
161 |
Plaquenil*25cpr riv 200mg |
- |
- |
- |
- |
084 1件: 84 💬 |
162 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
163 |
Prednison |
- |
- |
- |
- |
046 3件: 46, 84, 113 💬 |
164 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
165 |
Procedure: bronchoalveolar lavage (bal) |
- |
- |
- |
- |
084 1件: 84 💬 |
166 |
Procedure: bronchoscopy with bronchoalveolar lavage |
- |
- |
- |
- |
084 1件: 84 💬 |
167 |
Procedure: ebb + tblb + bal |
- |
- |
- |
- |
084 1件: 84 💬 |
168 |
Procedure: ebus guided transbronchial forceps biopsy (ebus-tbfb) |
- |
- |
- |
- |
084 1件: 84 💬 |
169 |
Procedure: ebus guided transbronchial needle aspiration (ebus-tbna) |
- |
- |
- |
- |
084 1件: 84 💬 |
170 |
Procedure: endobronchial forceps biopsy |
- |
- |
- |
- |
084 1件: 84 💬 |
171 |
Procedure: eus-fna/ebus-tbna + bal |
- |
- |
- |
- |
084 1件: 84 💬 |
172 |
Procedure: large bore (19g) histologic needle biopsy of the mediastinal lymph nodes |
- |
- |
- |
- |
084 1件: 84 💬 |
173 |
Procedure: skin biopsy |
- |
- |
- |
- |
019 2件: 19, 84 💬 |
174 |
Procedure: venipunctures |
- |
- |
- |
- |
084 1件: 84 💬 |
175 |
Propofol |
Propofol |
1件: D00549 D00549 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 8件: 6 , 21, 22, 34, 46, 84, 98, 296 💬 |
176 |
Quercetin |
Quercetin |
- |
- |
- |
084 5件: 84, 85, 192, 285, 299 💬 |
177 |
Radiation: rubidium pet |
Rubidium |
- |
- |
- |
084 1件: 84 💬 |
178 |
Rapamune |
- |
- |
- |
- |
002 8件: 2 , 60, 66, 67, 84, 158, 278, 280 💬 |
179 |
Remicade |
- |
- |
- |
- |
040 9件: 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
180 |
Repository corticotropin injection |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 5件: 2 , 13, 46, 84, 222 💬 |
181 |
Repository corticotropin injection -treatment extension |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 1件: 84 💬 |
182 |
Rifampin |
Rifampicin |
1件: D00211 D00211 💬 |
- |
- |
006 5件: 6 , 13, 84, 86, 299 💬 |
183 |
Rifampin and azithromycin. |
Azithromycin |
4件: D00211 D00211, D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
084 1件: 84 💬 |
184 |
Riociguat |
Riociguat |
1件: D09572 D09572 💬 |
GUCY1A1 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 6件: 51, 84, 86, 88, 225, 299 💬 |
185 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
186 |
Roflumilast |
Roflumilast |
1件: D05744 D05744 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
084 2件: 84, 299 💬 |
187 |
Rubidium |
Rubidium |
- |
- |
- |
084 2件: 84, 86 💬 |
188 |
Sandostatin lar |
- |
- |
- |
- |
067 4件: 67, 84, 193, 227 💬 |
189 |
Sarilumab |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 5件: 41, 46, 84, 107, 271 💬 |
190 |
Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1 |
Sarilumab |
1件: D10161 D10161 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
084 1件: 84 💬 |
191 |
Schisandra chinensis extract |
- |
- |
- |
- |
084 1件: 84 💬 |
192 |
Seasonal influenza vaccine available for the 2012-2013 vaccine campaign |
- |
- |
- |
- |
084 1件: 84 💬 |
193 |
Selexipag |
Selexipag |
1件: D09994 D09994 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 5件: 51, 70, 84, 86, 88 💬 |
194 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
195 |
Sirolimus ointment |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
084 1件: 84 💬 |
196 |
Tadalafil |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
197 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
198 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
199 |
Tofacitinib 5 mg twice daily |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
084 1件: 84 💬 |
200 |
Tofacitinib 5mg [xeljanz] 1 year open-label extension |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
084 1件: 84 💬 |
201 |
Tofacitinib 5mg oral tablet [xeljanz] 16 week trial |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
084 1件: 84 💬 |
202 |
Tracleer |
- |
- |
- |
- |
013 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬 |
203 |
Tranilast |
Tranilast |
1件: D02027 D02027 💬 |
- |
- |
046 4件: 46, 84, 106, 113 💬 |
204 |
Treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 6件: 51, 84, 85, 86, 88, 210 💬 |
205 |
Uptravi |
- |
- |
- |
- |
084 3件: 84, 86, 88 💬 |
206 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
006 8件: 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
207 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
208 |
Ustekinumab liquid in prefilled syringe |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
084 1件: 84 💬 |
209 |
Vitamin d2 |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
084 2件: 84, 299 💬 |
210 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |